The informed consent (IC) process allows the subject to voluntarily decide whether or not his/her participation in research. Generally, ICs are difficult to read documents that do not include all stakeholders’ perceptions. Therefore, informative IC should be a process that include needed information under a gender and age perspective, more importantly if these are vulnerable populations. The relationship between science and society should favour the engagement inclusion of citizens in the informed consent process, and this must be done with especial attention to gender and ethics considerations. The IC process should also improve health literacy in the citizens.
The I-CONSENT project presents a simple work plan structure with a WP1 aimed to analyze baseline knowledge of IC, WP2 presenting innovative solutions and WP3 proposing new guidelines, disseminated in WP4. For this i-CONSENT consortium presents a multi-stakeholder community of partners from academia, public health, patient organizations, clinicians and private sector, including pharma and SMEs, and a set of activities that will maximize the collection (workshops) and dissemination (communication plan) of information.
Specifically, and to ensure alignment with the Topic scope, the project will use a selection of 3 different vaccines as study frame to improve guidelines for informed consents. These do focus on vulnerable age populations with very special emphasis on gender: Human Papilloma Virus (HPV) vaccines (preadolescent and adolescents), Meningitis (adults) and Respiratory Syncitial Virus (pregnant women). Besides Gender and Ethic issues as centre of the proposal, the project will consider the interaction of age and gender, with its specifics as comprehension of medical information, oral and written language, and availability and use of new technologies will also be considered.
Fields of science
- social sciencessociologygender studiesgender equality
- natural sciencesbiological sciencesmicrobiologyvirology
- medical and health scienceshealth sciencespublic health
- medical and health scienceshealth sciencesinfectious diseasesDNA viruses
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
- H2020-EU.5.g. - Take due and proportional precautions in research and innovation activities by anticipating and assessing potential environmental, health and safety impacts
- H2020-EU.5.f. - Develop the governance for the advancement of responsible research and innovation by all stakeholders, which is sensitive to society needs and demands and promote an ethics framework for research and innovation
- H2020-EU.5.c. - Integrate society in science and innovation issues, policies and activities in order to integrate citizens' interests and values and to increase the quality, relevance, social acceptability and sustainability of research and innovation outcomes in various fields of activity from social innovation to areas such as biotechnology and nanotechnology
- H2020-EU.5.b. - Promote gender equality in particular by supporting structural change in the organisation of research institutions and in the content and design of research activities
Call for proposal
See other projects for this call
Funding SchemeCSA - Coordination and support action
28760 Tres Cantos Madrid
BS31 1AE Keynsham
BS1 1LT Bristol